Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Inflammatory bowel disease

P R Gibson1, R P Anderson

  • 1Royal Melbourne Hospital, Vic. p.gibson@medicine.unimelb.edu.au

The Medical Journal of Australia
|November 6, 1998
PubMed
Summary
This summary is machine-generated.

Inflammatory bowel disease (IBD) diagnosis relies on clinical suspicion, endoscopy, and biopsies. Treatment varies for active disease versus remission, with corticosteroids for flares and immunosuppressants for chronic management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The role of clay minerals in the preservation of Precambrian organic-walled microfossils.

Geobiology·2023
Same author

Realization of a deeply subwavelength adiabatic optical lattice.

Physical review research·2021
Same author

Topological features without a lattice in Rashba spin-orbit coupled atoms.

Nature communications·2021
Same author

Whole blood interleukin-2 release test to detect and characterize rare circulating gluten-specific T cell responses in coeliac disease.

Clinical and experimental immunology·2021
Same author

Nutritional profile of rodent diets impacts experimental reproducibility in microbiome preclinical research.

Scientific reports·2020
Same author

Serum cytokines elevated during gluten-mediated cytokine release in coeliac disease.

Clinical and experimental immunology·2019
Same journal

Still Treating Yesterday's Risk? Reconsidering Antiviral Use for Mild-to-Moderate COVID-19 Cases in a Broadly Immune Population.

The Medical journal of Australia·2026
Same journal

Striving for Racial Equity in Oral Cancer Research: A Case Study.

The Medical journal of Australia·2026
Same journal

Progressing Cross-Sector Collaboration for People With Eating Disorders and Higher Weight: Priority Actions From an Expert Roundtable Using a Modified Nominal Group Technique.

The Medical journal of Australia·2026
Same journal

Self-Poisoning With Prazosin and Its Off-Label Use in Australia, 2014-2024: Analysis of NSW Poisons Information Centre Data.

The Medical journal of Australia·2026
Same journal

Drivers of Vaccine Uptake for Aboriginal and Torres Strait Islander Children to Inform Tailored Strategies: A Qualitative Study Exploring Health Service Provider Perspective.

The Medical journal of Australia·2026
Same journal

Four Urgent Actions for the Rights to Culturally Safe Breastfeeding for Aboriginal and Torres Strait Islander Mothers and Babies to Breastfeed in Neonatal Intensive Care Environments.

The Medical journal of Australia·2026
See all related articles

Area of Science:

  • Gastroenterology
  • Immunology

Background:

  • Inflammatory bowel disease (IBD) arises from complex genetic and environmental interactions.
  • Smoking is a significant environmental factor influencing IBD development and progression.

Purpose of the Study:

  • To outline the diagnostic pathway for IBD.
  • To differentiate treatment strategies for active IBD and long-term remission.

Main Methods:

  • Diagnosis involves clinical suspicion, colonoscopy with biopsies, barium radiology, and fecal analysis.
  • Treatment distinguishes between active disease management and remission maintenance.

Main Results:

  • Corticosteroids are primary for active IBD; immunosuppressants are crucial for chronic disease.

Related Experiment Videos

  • Mesalazine and immunosuppressants are effective for maintaining remission in both ulcerative colitis and Crohn's disease.

    • Conclusions:

    • Effective IBD management requires tailored approaches for active phases and remission.
    • Smoking cessation is critical for patients with Crohn's disease to prevent disease progression.